The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine for clinical trials in the search for a cure for COVID-19.
Director-General of the agency, Mojisola Adeyeye, made the announcement on Friday at the NAFDAC headquarters in Lagos.
Nigeria follows in the steps of the US, which has commenced the use of anti-malaria drug, Chloroquine on clinical trial basis, for the treatment of Coronavirus.
The Guardian
